Application of N-acetylglucosamine in preparing kit for detecting tumor

A technology of acetylamino and glucose, which is applied to the application field of N-acetylglucosamine in the preparation of kits for tumor detection, can solve the problems of difficult replication, unclear structure and the like, and achieve the effect of improving the early diagnosis rate

CN104198707AInactive Publication Date: 2014-12-10范飞舟 +1
4 Cites 15 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2014-12-10
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses application of N-acetylglucosamine in preparing a kit for detecting tumor. According to the technical scheme disclosed by the invention, the detection rate of the tumor is greater than 90%, and the tumor specificity is greater than 95%. The early-stage diagnostic rate of the tumor is greatly increased. The kit is applicable to early-stage general survey on tumor of normal people.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the application of N-acetylglucosamine in the preparation of a kit for detecting tumors. Background technique

[0002] Since the 1980s, experts have used hybridoma technology to obtain tumor-specific macromolecular glycoprotein antigens (carbohydrate antigen, CA), and developed a monoclonal antibody recognition system. So far, in the field of in vitro early diagnosis reagents for tumors, there are two analysis methods: competitive analysis and non-competitive sandwich analysis. From the perspective of laboratory detection, tumor markers are divided into serum / plasma tumor markers and histiocytic tumor markers. Serum / plasma tumor markers are roughly divided into three categories: 1) Embryonic antigens. Antigens that are expressed in embryos, not expressed in normal adults, and re-expressed with tumorigenesis, such as AFP and CEA. 2) Tumor-associated glycolipids and glycoproteins. CA199, CA50, CA242, CA724, CA125, CA153, etc....

Examples

Embodiment 1

[0076] Example 1. Discovery and identification of N-acetylglucosamine for tumor detection

[0077] The inventors of the present invention have found that the content of N-acetylglucosamine in the blood of tumor patients is significantly different from that in healthy people.

[0078]In the present invention, the blood of tumor patients is directly analyzed by SELDI and MELDI mass spectrometry in vitro, to obtain the special sugar structure map of tumor patients, and to find the specific spectral lines of tumors, thereby discovering tumor-specific sugar structures, Glycoprotein, what we have discovered so far is the special sugar group of GlcNAc (N-acetylglucosamine, N-acetylglucosamine), and then the target sugar obtained by separation and purification by polyacrylamide electrophoresis, high pressure liquid chromatography, and lectin affinity chromatography protein.

[0079] We tried the method of affinity chromatography (Mu-GlcNAc was attached to the monoclonal antibody Ma69...

Embodiment 2

[0088] Example 2. A method for screening specific binding bodies to detect tumors using N-acetylglucosamine (sandwich method)

[0089] Determination of Mu-GlcNAc antigen in sandwich mode, the principle is as follows figure 2 shown.

[0090] (1) Materials and methods

[0091] 1 Reagents and tumor patient serum samples

[0092] 1.1 Reagent Ma695 monoclonal antibody (Mab), CanAg Diagnostics AB, Sweden, biotin (biotin)-linked Aptamer (the aptamer shown in sequence 1 prepared as in Example 1, biotin-labeled), Mu-GlcNAc antigen, Self-affinity chromatography extraction (see Example 1); it can also be purchased from Beijing Yonghan Xinggang Biotechnology Co., Ltd.

[0093] 1.2 Serum specimens of cancer patients The blood samples of cancer patients were obtained from the Cancer Hospital of the Chinese Academy of Medical Sciences and the 301 Hospital of the People's Liberation Army, and the diagnosis of the patients was confirmed by pathology.

[0094] 2 methods

[0095] 2.1 Prepa...

Embodiment 3

[0115] Embodiment 3, single conjugate assay method detects tumor

[0116] The principle of the single-conjugate assay method is as follows: Figure 4A and Figure 4B , using the specific binding body aptamer (shown in sequence 1) of N-acetylglucosamine. Single-conjugate analysis uses only N-acetylglucosamine-specific binding body as the recognition body; single-conjugate analysis uses N-acetylglucosamine-specific binding body to directly identify N-acetylglucosamine in the detection object; The essence of conjugate analysis is the specific combination of conjugate and -GlcNAc.

[0117] The specific method is as follows:

[0118] (1) Materials and methods:

[0119] 1 Reagents and tumor patient serum samples

[0120] 1.1 Reagents: aptamer biotin-MA153-A, Beijing Yonghan Xinggang Biotechnology Co., Ltd.; MA153 antigen, Beijing Yonghan Xinggang Biotechnology Co., Ltd.; Streptavidin, Sigma USA.

[0121] 1.2 Serum specimens of cancer patients The serum samples of cancer patien...